Related Experiment Video

Updated: Aug 6, 2026

A Simple Protocol for Platelet-mediated Clumping of Plasmodium falciparum-infected Erythrocytes in a Resource Poor Setting
07:27

A Simple Protocol for Platelet-mediated Clumping of Plasmodium falciparum-infected Erythrocytes in a Resource Poor Setting

Published on: May 16, 2013

Thrombocytopenia and Plasmodium falciparum malaria in children with different exposures

F Moulin1, F Lesage, A-H Legros

  • 1Hopital Saint Vincent de Paul, Paris, France.

Archives of Disease in Childhood
|May 27, 2003
PubMed

Insights

Thrombocytopenia (low platelet count) is common in children with acute Plasmodium falciparum malaria. This finding is not linked to severe malaria, but low parasite levels with thrombocytopenia may delay diagnosis.

Area of Science:

  • Tropical Medicine
  • Pediatric Infectious Diseases
  • Hematology

Background:

  • Plasmodium falciparum malaria is a significant global health concern, particularly in children.
  • Thrombocytopenia is a frequently observed complication of malaria.
  • Understanding the prevalence and significance of thrombocytopenia in pediatric malaria is crucial for effective management.

Purpose of the Study:

  • To investigate the occurrence and clinical relevance of thrombocytopenia in children with acute Plasmodium falciparum malaria.
  • To compare thrombocytopenia rates in children with varying exposure levels (travelers vs. endemic populations) and disease severity.

Main Methods:

  • Cross-sectional study involving children diagnosed with acute Plasmodium falciparum malaria.
  • Data collected from pediatric populations in Paris (travelers), Dakar (intermittent exposure), and Libreville (perennial exposure).
  • Analysis of initial thrombocytopenia prevalence and its association with severe malaria outcomes or cerebral malaria.

Main Results:

  • Initial thrombocytopenia was observed in 43-58% of children with Plasmodium falciparum malaria.
  • Thrombocytopenia was not significantly more frequent in children experiencing severe malaria attacks or cerebral malaria.
  • Low parasitemia, when accompanied by thrombocytopenia, may lead to misdiagnosis and delayed treatment.

Conclusions:

  • Thrombocytopenia is a common finding in pediatric acute Plasmodium falciparum malaria, irrespective of disease severity.
  • The presence of thrombocytopenia, especially with low parasitemia, warrants careful consideration to avoid diagnostic delays.
  • Further research may elucidate the specific mechanisms and implications of thrombocytopenia in pediatric malaria.

More Related Videos

Measuring Naturally Acquired Phagocytosis-Inducing Antibodies to Plasmodium falciparum Parasites by a Flow Cytometry-Based Assay09:57

Measuring Naturally Acquired Phagocytosis-Inducing Antibodies to Plasmodium falciparum Parasites by a Flow Cytometry-Based Assay

Published on: August 6, 2020

In Vitro Assay of Plasmodium-Infected Red Blood Cell Killing by Cytotoxic Lymphocytes08:20

In Vitro Assay of Plasmodium-Infected Red Blood Cell Killing by Cytotoxic Lymphocytes

Published on: August 17, 2022

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Diversity of Protists II01:27

Diversity of Protists II

Alveolates are a group of organisms recognized by the presence of alveoli, which are cytoplasmic sacs located beneath the cell membrane. While their function remains uncertain, alveoli may help regulate water balance by controlling how much water enters and leaves the cell. In dinoflagellates, these structures may serve as armor plates. There are three major types of alveolates: ciliates, which move using cilia; dinoflagellates, which use flagella for movement; and apicomplexans, which are...
Malaria01:29

Malaria

Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
Toxoplasmosis01:28

Toxoplasmosis

Toxoplasmosis, a zoonotic disease caused by the protozoan Toxoplasma gondii, poses significant public health challenges globally due to its high seroprevalence and varied clinical manifestations. As an obligate intracellular parasite, T. gondii can infect all warm-blooded vertebrates, but felids are its only definitive hosts, shedding unsporulated oocysts into the environment. Humans typically acquire the infection through ingestion of tissue cysts in undercooked meat or oocysts from...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...